[ad_1]
BOSTON —Boston Life Sciences Times, New England’s premier source for news in pharma, biotech, medtech, and public health, has announced the winners of its 2025 Vanguard Awards, honoring companies and leaders driving innovation, collaboration, and transformative impact across the life sciences ecosystem.
This year’s honorees were selected from over 100 nominations by the readers, reviewed by the Boston Life Sciences Times editorial team.
“These pioneering organizations and leaders represent the best of what our life sciences community stands for — vision, courage, and an unwavering commitment to improving human health,” said Upendra Mishra, Publisher of Boston Life Sciences Times and its sister publications Boston Real Estate Times, IndUS Business Journal and India New England News. “Each of them is reshaping the future of science and medicine in ways that will be felt for generations.”
Mishra added, “Boston remains the global capital of life sciences because of companies like these — who innovate not just in the lab, but in how they think, collaborate, and lead. The Vanguard Awards celebrate that spirit of excellence and inspiration.”
The 2025 Vanguard Awards Ceremony will take place on Thursday, December 11, 2025, at the Burlington Marriott Hotel in Burlington, MA, from 7:30 to 10:00 a.m. Honorees will also be profiled in an upcoming issue of Boston Life Sciences Times.
To reguster for the award ceremony, please click here.
Life Sciences Company of the Year
Vertex Pharmaceuticals
Vertex continues to set the standard for transformative therapies, developing and commercializing groundbreaking treatments for serious diseases such as cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain. With a robust R&D pipeline spanning nephrology, neurology, and genetic diseases, Vertex’s research is guided by deep biological insights and a commitment to curative outcomes. Founded in 1989 and headquartered in…
[ad_2]